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A B S T R A C T
Purpose: The aim of the study was to retrospectively analyze the electroclinical features, etiology,
treatment, and prognosis of 29 patients with Landau–Kleffner syndrome (LKS) with a long-term follow-
up.
Methods: Inclusion criteria were a diagnosis of LKS with: (1) acquired aphasia or verbal auditory
aphasia; (2) with or without focal seizures, secondarily generalized tonic-clonic seizures, absences, or
atonic seizures.
Results: Mean follow-up was 12 years. All cases except six had seizures. Before the onset of aphasia,
developmental language and behavioral disturbances were present in 19 and 14 patients, respectively.
All patients had verbal auditory agnosia. Aphasia was severe in 24 patients and moderate in ﬁve.
Nonlinguistic cognitive dysfunctions were moderate in 14 patients. Behavioral disturbances were found
in 16 patients. During the continuous spike-and-wave discharges during slow sleep phase, the spike-
wave index was >85% in 15, 50–85% in eight, and 30–50% in four. In two patients, the EEG recording
showed occasional bilateral spikes, without continuous spike-and-wave discharges during slow sleep. In
this phase, the awake EEG recording showed more frequent interictal abnormalities, predominantly in
the temporal regions. Eight patients recovered language completely, but the remaining patients continue
to have language deﬁcits of different degrees.
Conclusion: Landau–Kleffner syndrome is an epileptic encephalopathy characterized by acquired verbal
auditory aphasia and seizures in most of the patients associated with continuous or almost continuous
spike-and-wave discharges during slow wave sleep. The most commonly used treatments were
clobazam, ethosuximide, sulthiame. High-dose steroids were also administered. Adequate and early
management may avoid language and cognitive deterioration.
 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Landau–Kleffner syndrome (LKS) or acquired epileptic aphasia
is a childhood disorder in which acquired aphasia and epileptiform
electroencephalographic (EEG) abnormalities are associated.
Epileptic seizures are infrequent and not a prerequisite for
Landau–Kleffner syndrome. Other clinical ﬁndings include cogni-
tive impairment and global behavioral regression.1–7 Since the
original report by Landau and Kleffner in 1957, hundreds of cases
of LKS have been reported in the literature.1–8
The age at onset is estimated to range from ages 2–8 years, with
a peak between 5 and 7 years. Onset as early as 18–22 months and
as late as 13–14 years has also been reported. Boys are affected
twice as frequently as girls. The most prominent deﬁning feature of* Corresponding author at: Department of Neurology, Hospital de Pediatrı´a ‘‘Prof.
Dr. Juan P. Garrahan’’, Combate de los Pozos 1881, CP 1245 Buenos Aires, Argentina.
Tel.: +54 11 4824 0299; fax: +54 11 4843 6116.
E-mail address: rhcaraballo@arnet.com.ar (R.H. Caraballo).
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http://dx.doi.org/10.1016/j.seizure.2013.09.016Landau–Kleffner syndrome is an acquired aphasia. The type of
aphasia typically is a verbal auditory agnosia, which is the failure to
give a semantic signiﬁcance to the different sounds.2–12 The loss of
receptive language is followed by expressive aphasia, with a
marked reduction in spontaneous speech. The aphasia has a
subacute onset and a progressive course, with a ﬂuctuating pattern
of spontaneous improvements and exacerbations. The most
frequently observed behavioral problems are attentional deﬁcits,
impulsivity, distractibility, and hyperactivity.10–12
Electroencephalographic ﬁndings during wakefulness may be
bilateral centrotemporal, posterior temporal, and parieto-occipital
spikes and waves. As soon as the patient falls asleep, continuous
and diffuse slow spikes and waves appear, mainly at 1.5–2.5 Hz,
persisting through all the slow-sleep stages. This pattern of
continuous spikes and waves during slow sleep (CSWS) or
electrical status epilepticus in sleep (ESES) in patients with
Landau–Kleffner syndrome tends to be unilateral or clearly
lateralized. Until a deﬁnite name for this pattern is decided on,
here we will use the abbreviation of CSWS/ESES to deﬁne the
typical EEG features. The presence of CSWS/ESES in LKS appears tovier Ltd. All rights reserved.
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evident for more than 3 years may be associated with long-term
language deﬁcits.2–10,12
Despite the severe electroencephalographic abnormalities,
seizures never occur in 20–30% of patients. When present, seizures
are infrequent and easy to control. Semiology of the seizures
observed in LKS can vary, but includes partial complex (with focal
motor and atypical absence symptoms), partial clonic, generalized
tonic-clonic, and atonic seizures.3–12
By convention LKS is not related to organic brain lesions and
occurs in previously normal children who have already developed
age-appropriate speech. However, there are reports of ‘‘clinically
deﬁned’’ LKS in patients with a congenital or acquired brain lesion
and in children who demonstrated substantial pre-existing
anomalies of language development prior to their language
regression.10,12–14
Taking into account the relationship between the occurrence of
CSWS/ESES and the language deterioration, early and aggressive
therapy is mandatory. Several antiepileptic drugs (AEDs), such as
valproate, ethosuximide, clonazepam, or clobazam have been
demonstrated to be effective. Other AEDs, such phenytoin,
phenobarbital, and especially carbamazepine and oxcarbazepine
as well as new AEDs, such as lamotrigine and topiramate are
generally to be avoided because they have been associated with
exacerbations of the epileptiform discharges of CSWS/ESES. A
combination of benzodiazepines and ethosuximide has been
used.12,15,16 An association of valproic acid and ethosuximide is
still favored by different groups.16,17 Sulthiame and levetiracetam
have also been considered a good option.12,16 Corticosteroids have
been reported to markedly improve the evolution of the
disease.4,12,18 Intravenous immune globulin demonstrated prom-
ising results in some cases of LKF.19 The ketogenic diet and vagus
nerve stimulation,16,20 as well as subpial transection,21 has led to
some clinical improvement in selected patients.
LKS is deﬁned as an epileptic encephalopathy, in which a
deterioration of cognitive, sensory, and/or motor functions results
from epileptic activity.22–24 Currently, LKS is considered as a
clinical variant or subtype of encephalopathy related to CSWS/ESES
by different authors,12,25–27 however, in the new diagnostic
scheme of the ILAE they are considered as separate entities.24
The aim of this study was to describe the electroclinical
features, etiology, treatment, and prognosis of 29 patients with LKS
with a long-term follow-up.
2. Methods
We conducted a retrospective, descriptive study of 29
consecutive patients (20 boys and 9 girls) with LKS followed
between 1990 and 2012. Fifteen of them were previously
published.4 All patients met the inclusion criteria of a diagnosis
of LKS with: (1) acquired aphasia or verbal auditory aphasia; (2)
with or without focal seizures, secondarily generalized tonic-clonic
seizures, absences, or atonic seizures.
Children with other epileptic encephalopathies (ESES/CSWS
syndrome, myoclonic astatic epilepsy with cognitive deterioration,
and Lennox–Gastaut syndrome) and focal epilepsies with second-
ary bilateral synchronies not fulﬁlling the criteria for the LKS were
excluded. Structural cases with acquired aphasia were also
excluded.
In this study all patients underwent at least three prolonged
sleep EEGs (more than one hour), and 10 of these 29 patients
underwent all-night video-EEG in addition to the routine EEG
recordings. The spike-wave index (SWI) on the non-REM-sleep EEG
was visually calculated based on the total number of spike-waves
per unit of time or based on the information provided by the
epileptologist in the clinical charts. The ranges of the indexconsidered were: >85%, 50–85%, and 30–50%. The SWI was
quantiﬁed by a single rater (RHC), however, as this was a long-term
study subtle differences in the measurement of the index due to
changes in the quality of the EEG equipment over the years cannot
be excluded.
Brain magnetic resonance imaging (MRI) was obtained in all
patients, except ﬁve. In these ﬁve patients, the brain computed
tomography scan was normal. Prolonged sleep EEGs lasting at least
2 h were repeated two or more times per year. Various
neuropsychological tests to evaluate comprehension, expression,
repetition, naming, pointing, visuomotor integration, and verbal
and performance IQ were done depending on the characteristics
(age, collaboration of the child, etc.) of each patient.11
Biochemical controls, urine analysis, and plasma levels of
classic AEDs were studied. The AEDs as well as other treatment
options, such as steroids, gamma-globulins, and the ketogenic diet,
were analyzed.
Determination of efﬁcacy of the AED treatment was based on
electroclinical criteria and neuropsychological testing. Response of
the EEG abnormalities was graded as a normal recording, a more
than 75% improvement of the SWI, a more than 50% improvement
of the SWI, a more than 30% improvement of the SWI, focalization
of the continuous generalized paroxysms, and no response. The
percentages of improvement of the SWI were related to the
baseline SWI. Clinical response was considered as the decrease of
cognitive and behavioral disturbances and was graded as complete
disappearance of clinical manifestations and a clinical improve-
ment of more than 75%, more than 50%, or more than 30%.
The study was conducted at a single institution (Garrahan
Hospital, Buenos Aires) and was approved by the institutional
review board and ethics committee.
Continuous variables were analyzed using the Student’ t-test.
Categorical variables were analyzed using the Fisher’ exact test.
3. Results
3.1. Clinical features
All cases (79.4%) except six had seizures. The mean and median
ages at seizure onset were 6.5 and 7 years, respectively (range 2–12
years). Fifteen patients (65.2%) had focal motor seizures, ﬁve
(21.7%) had complex focal seizures, seven (31.7%) had focal
seizures with secondary generalization, and two (8.6%) had
apparently generalized seizures. Atypical absences were found
in 11 (47.8%) and positive myoclonus in three patients (13%). Tonic
seizures were not registered. Eleven patients (47.8%) only had
seizures during sleep, two patients (8.6%) only had seizures while
awake, and 10 (43.4%) had seizures both during sleep and while
awake. At onset, eight patients had electroclinical features of
rolandic epilepsy, and two others had an association of two
epileptic syndromes (Panayiotopoulos syndrome and rolandic
epilepsy).
Fourteen children had their ﬁrst seizures before the onset of
language disturbances, seven had their ﬁrst seizures at the same
time the language disturbances occurred, and in two the seizures
occurred after the onset of verbal auditory agnosia.
Previous to the aphasia, developmental language disturbances
were present in 19 of 29 patients (65.5%) and behavioral
disturbances in 14 patients (48.3%). By deﬁnition, all patients
had verbal auditory agnosia. The median and mean ages at the
onset of aphasia were 5 and 5.5 years, respectively (range 2–9
years). An insidious course of the acquired aphasia was registered
in 16 patients (55.1%), a subacute course was observed in 10
patients (34.4%), and an acute course was observed in three
patients (10.3%). Aphasia was severe in 24 patients (82.8%) and
moderate in ﬁve (17.2%), and ﬂuctuation of the aphasia was
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functions were normal in 15 patients (51.7%) and moderately
affected in the remaining 14 (48.3%). Attention deﬁcit hyperactivi-
ty disorder was found in 15 patients (51.7%), aggressiveness in four
(13.7%), memory deﬁcit in four others (13.7%), and impaired
temporospatial orientation in two patients (6.8%). None of the
patients in this series was found to have psychotic and autistic
behavior.
3.2. Electroencephalographic ﬁndings
At onset, the awake EEG recordings showed focal epileptiform
abnormalities in 10 patients (34.4%), bilateral abnormalities in 10
(34.4%), and focal abnormalities associated with generalized
paroxysms in nine patients (31.2%). During sleep, the EEG
abnormalities increased in frequency.
In the phase immediately previous to CSWS/ESES onset, a
considerable increase of the interictal abnormalities was observed
both during wakefulness and sleep. These abnormalities were
bilateral, most of the time synchronous, symmetric or asymmetric,
and occurred predominantly in the fronto-temporal regions.
During the CSWS/ESES phase, the SWI was >85% in 15, 50–85%
in eight, and <50% in four (Figs. 1 and 2). The two remaining
patients had occasional bilateral spikes, without CSWS/ESES. In
this phase, the awake EEG recording showed more frequent focal
abnormalities, multifocal spikes, and bilateral spikes and waves at
2–3 Hz, predominantly in the temporal regions. Additionally to the
CSWS/ESES, the sleep EEG recordings showed focal epileptic
activity in nine patients (31.2%), bilateral epileptic activity in 14
patients (48.3%), and both focal and diffuse epileptic abnormalitiesFig. 1. EEG recording shows continuous spike-and-in six cases (20.6%). The mean duration of CSWS/ESES was 8
months (range 2–16 months).
In two patients (6.8%) the CSWS/ESES recurred, twice in one
patient and three times in the other, however, in all cases either
normalization of the EEG or disappearance of the CSWS/ESES was
persistent during follow-up.
Personal and family history of febrile seizures and epilepsy Six
patients (20.6%) had a positive family history of epilepsy and four
(13.7) of febrile seizures. Three patients (10.3%) had a personal
history of febrile seizures.
3.3. Treatment
Outcome according to the clinical criteria to evaluate response
was seizure freedom and repeated sleep EEGs showing normali-
zation or disappearance of the CSWS/ESES in all patients, except in
three cases who continued with sporadic seizures and isolated EEG
abnormalities. No correlation was found between types of
treatment, improvement in the SWI, and language or cognitive
improvement.
3.4. Outcome
Average follow-up was 12 years (range 3–21 years) for 29
children. At the last control, 26 patients had remained seizure free.
Three cases have isolated seizures with EEG recordings showing
focal spikes in two and bilateral spikes in one.
Not all patients with LKS in our series underwent full
neuropsychological testing and thus, subtle deﬁcits may not have
been detected. This is a limitation in our study.wave activity in more than 85% of slow sleep.
Fig. 2. Sleep EEG recording shows asymmetric spike-and-wave activity in less than 85% of slow sleep.
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were early onset of aphasia and the duration of CSWS. Eight
patients (27.5%) completely recovered language and the remaining
patients continue to have language deﬁcits and/or cognitive
disturbances of different degrees. Normalization or a signiﬁcant
improvement of the EEG was a necessary condition for complete
language recovery, but not all patients with a normal EEG
normalized the language disturbances. At the last evaluation, six
children (20.7%) were attending a normal school, ﬁve children
(17.2%) were receiving special education, and ﬁve (17.2%) were
going to a school for deaf children. After a long period of follow-up
(minimum 10 years) of the remaining 13 patients, six patients did
not show any language abnormalities and led a normal life, four
had persistent oral or written language difﬁculties and led a
relatively normal life, and three had severe language abnormalities
with signiﬁcantly reduced oral language and could not live
independently. No long-term deterioration of intellectual func-
tioning was observed in any of the patients even when severe
aphasia persisted into adulthood. In Table 1, the main electro-
clinical ﬁndings, treatment, and outcome are described.
4. Discussion
Our series of patients had acquired aphasia associated or not
with CSWS/ESES compatible with LKS. The study conﬁrms that LKS
is an epileptic encephalopathy with a broad range of SWI. Only two
patients had occasional and bilateral spikes and did not present
with CSWS/ESES. Language recovery was observed in the drug
responders. It seems that even a modest or less continuous
activation of paroxysmal activity during sleep may cause language
dysfunction, and this ﬁnding seems to limit the role of CSWS/ESES
in determining selective neurological deterioration. Thus, thequality of the EEG abnormalities may be as important as the SWI
during slow sleep, as we previously observed in patients with the
ESES/CSWS syndrome.16 This suggests that the epileptiform
discharges per se, regardless of the absolute percentage of the
SWI, during a particular period of the sleep and depending on age
may play a crucial role in the development of acquired aphasia.
From the neurolinguistic point of view, all our patients
presented with moderate to severe auditory verbal agnosia.
Comprehensive difﬁculties were followed by deﬁcits in expressive
language, word ﬁnding alterations, phonemic and semantic
paraphasias, and other communication problems extending in
some cases to absolute mutism. Nonlinguistic cognitive functions
were affected in approximately half of the patients.
Cognitive results in our patients were very similar to those
previously described in the literature.10–12,28 Patients with LKS and
autistic regression have been published,10,12,29 however, no
psychotic or autistic manifestations were observed in our patients.
The limitation of our study was that subtle cognitive deﬁcits may
not have been detected, because of a lack of more detailed
cognitive testing.
In our series the etiology was unknown in all patients, and
benign childhood epilepsy with centro-temporal spikes (BCECTS)
was the most frequently found electroclinical manifestation before
the onset of the acquired aphasia. Similar cases have been
published.15,30–34 In these cases a probable genetic cause may
be considered. Recently, a clinical genetic study of the epilepsy-
aphasia spectrum has stated that the seizure rate in relatives of
probands with this clinical spectrum suggests that the underlying
genetic inﬂuence of LKS is consistent with a complex inheritance
and is similar to BCETS. The phenotypic pattern observed in the
affected relatives comprised predominantly febrile seizures and
focal seizures. These ﬁndings suggest that a shared genetic
Table 1













EEG ﬁndings Treatment Outcome Duration of
follow-up
(years)
1 4 FMS, SGTCS, AA 5 Severe  Dyslexia CSWS/ESES ETS Seizure free 21
>85% Severe LD
2 4 FCS, MS 5 Severe +  CSWS/ESES CLB Sporadic FMS 3
<50% MildLD
3 7 FMS, AA 3 Moderate +  CSWS/ESES CLB Seizure free 20
>85% Normal language
4 5 FCS, AA 7 Severe   CSWS/ESES ETS Seizure free 19
50–85% ModerateLD
5 8 FMS 4 Severe + Dyslexia CSWS/ESES STM Seizure free 7
>85% SevereLD
6 7 FMS, AA 6 Moderate   CSWS/ESES Steroids + VPA Seizure free 9.5
<50% Normal language
7 2 AGTCS, FMS 5 Severe +  CSWS/ESES Steroids + STM Seizure free 8.5
>85% Severe LD
8 12 FMS 5 Severe  Dyslexia CSWS/ESES STM Frequent FMS 9
50–85% Moderate LD
9 7.5 SGTCS, FMS 6 Severe +  CSWS/ESES ETS + VPA Seizures-free 6.5
<50% Moderate LD
10 6.5 FCS, AA 4 Moderate +  CSWS/ESES CLB + ETS Seizures-free 18.5
>85% Normal language
11 4 FMS 3 Severe +  CSWS/ESES Steroids + STM Sporadic FMS 10
>85% Moderate LD
12 8 FMS, AA 5 Severe +  CSWS/ESES CLB + ETS Seizure free 17.5
50–85% Normal language
13 5 FMS 6 Moderate   CSWS/ESES ETS Seizure free 7.5
>85% Mild LD
14 9 SGTCS, PMS 4 Severe   CSWS/ESES Steroids + VPA Seizure free
>85% Normal language 17
15 7 FMS, AA 4.5 Severe +  CSWS/ESES Steroids + STM Seizure free
50–85% Normal language 8
16 7 FCS, AA 5.5 Severe  Dyslexia CSWS/ESES CLB Seizure free
>85% ModerateLD 18
17 9 FMS 6.5 Severe + Dyslexia CSWS/ESES CLB + ETS Seizures-free 19
>85% ModerateLD
18 5 FCS, PMS 3.5 Severe   CSWS/ESES STM Seizure free 13.5
50–85% Normal language
19 9.5 FMS, AA 7.5 Severe +  Bilateral spikes CLB + STM Seizure free 8
mildLD
20 3.5 SGTCS 3.5 Severe +  CSWS/ESES ETS Seizure free 13.5
>85% Mild LD
21 7 FMS 8 Severe + Dyslexia CSWS/ESES ETS + VPA Seizure free 6.5
>85% ModerateLD
22 6.5 SGTCS 2 Severe + Dyslexia CSWS/ESES Steroids + VPA Seizure free 14.5
>85% Severe LD
23 7.5 AGTCS, PMS 6 Moderate  Dyslexia CSWS/ESES ETS Seizure free 9
50–85% Progressive
improvement LD
24 8 FMS, AA 4 Severe   CSWS/ESES ETS + VPA Seizure free 9.5
>85% Progressive
improvement LD
25 6 SGTCS 3.5 Severe + Dyslexia Bilateral spikes CLB + STM Seizure free 9
Moderate LD
26 6.5 FMS 2 Severe +  CSWS/ESES CLB Seizure free 9
50–85% Progressive
improvement LD
27 3 AA, PMS 6.5 Severe +  CSWS/ESES STM Seizure free 18
<50% Moderate LD
28 10 SGTCS 6 Severe +  CSWS/ESES CLB + ETS Seizure free 9
>85% Mild LD
29 6.5 FMS 9 Severe + CSWS/ESES CLB Seizure free 9.5
Dyslexia 50–85% Mild LD
VAA: verbal auditory agnosia; FMS: focal motor seizures; CFS: complex focal seizures; SGTCS: secondary generalized tonic-clonic seizures; LD: language deﬁcit; AGTCS:
apparently generalized tonic-clonic seizures; AA: atypical absences; PMS: positive myoclonic seizures.
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spectrum.33 Previously, a study on a spectrum from rolandic
epilepsy to LKS gave insights into possible genetic factors.34 More
recently, patients with epilepsy-aphasia spectrum associated with
GRIN2A mutations have been reported.35 Thus, it would be
important to conduct genetic studies in patients with CSWS/ESES
to corroborate these ﬁndings.There are reports of children with structural or idiopathic focal
epilepsies associated with CSWS/ESES in which classic antiepilep-
tic drugs, such as carbamazepine, oxcarbazepine, phenobarbital, or
phenytoin, induced CSWS/ESES; these should be avoided. Valproic
acid, lamotrigine, topiramate, and levetiracetam have also been
involved in sporadic cases, but further data are necessary to
conﬁrm this ﬁnding.16 To our knowledge, this phenomenon has not
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imide, or sulthiame.
Some important issues should be taken into account in the
pharmacological management of LKS. When patients have
electroclinical parameters that may predict an evolution to LKS,
the possibility to switch the initially used AEDs to the adequate
scheme to treat these patients should be evaluated. Particularly,
once the CSWS/ESES period has started, the offending AEDs should
be changed to clobazam, ethosuximide, or sulthiame, alone or in
combination. The association of valproic acid and ethosuximide is
another treatment option. In children who do not respond to AED
therapy, corticosteroids should be considered early to prevent
language disturbances.12,16,18 In refractory cases, gamma-globu-
lins, the ketogenic diet, and surgical treatment should also be taken
into account.16,19–21
In the management of our patients during the CSWS/ESES
phase, no response was found to the following AEDs: Valproic acid,
lamotrigine, topiramate, carbamazepine, oxcarbazepine, and
phenobarbital. A switch of these AEDs to ethosuximide, clobazam,
or sulthiame was the ﬁrst treatment step to signiﬁcantly improve
not only the seizure control and language disturbances, but also
the EEG abnormalities. Valproic acid was useful associated with
ethosuximide. Other treatment options were corticosteroids
associated with valproic acid in three, sulthiame in three, and
ethosuximide in two patients, respectively.
In the follow-up, eight patients of the 29 in our series
completely recovered language while the remaining patients
continue to have different degrees of language deﬁcits. Twelve
children go to a normal school, eight receive special education, and
ﬁve go to a school for deaf children. Other LKS patients with a long-
term follow-up have been published.36–39 Spontaneous remissions
within weeks or months after onset have been reported.6
Recurrence or worsening of aphasia may occur.40 After a variable
time, aphasia stabilizes and usually improves.6,40 In a study in a
large series of patients with a minimum follow-up of 7 years, 47.5%
had no oral expression or signiﬁcantly reduced oral language,
34.5% had persistent oral or written language abnormalities, and
18% had normal language.40 Nevertheless, long-term deterioration
of cognitive functioning is rarely found.40 Similar linguistic and
cognitive outcomes have been reported.10–12,36–39
Regarding the differential diagnosis, there are aspects that LKS
and epileptic encephalopathy with CSWS/ESES have in common.
LKS is a clinical syndrome and an important point for confusion is
that LKS may be associated or not with CSWS/ESES.25,41 The main
symptom of LKS is a loss of function limited to language (acquired
aphasia), whereas the CSWS/ESES syndrome is associated with a
broader spectrum of general cognitive impairments.10,12,16 Thus,
the two syndromes are distinct but have some overlap, especially
in their EEG markers. A clinical difference is that patients with LKS
have fewer seizures than those with the CSWS/ESES syndrome,
who present with a more global regression and have more
problematic epilepsy.27 On the other hand, some patients may
present with acquired aphasia as well as global regression, and
they may evolve from one syndrome to the other.27 Finally, a
structural cause is frequent in patients with epileptic encephalop-
athy with CSWS/ESES, while it is exceptional in patients with
LKS.12,16
Considering that LKS and epileptic encephalopathy with CSWS/
ESES present distinctive electroclinical features and etiologic
differences and despite the fact that they have been recognized as a
single epileptic syndrome, we suggest to use the term LKS for the
acquired epileptic aphasia and Tassinari syndrome for epileptic
encephalopathy with CSWS/ESES. These eponyms may be more
inclusive and comprise, for instance, patients with an SWI of less
than 80% or no CSWS/ESES at all. Future genetic studies in these
patients may elucidate if these syndromes are different types ofepileptic encephalopathies or the same epileptic syndrome with
two variants, the Landau–Kleffner type and the Tassinari type, in
recognition of the contribution of the authors that ﬁrst described
them.
5. Conclusions
Our study conﬁrms that the acquired epileptic aphasia
syndrome or LKS is an epileptic encephalopathy with a broad
SWI. In the majority of our patients the etiology was unknown, but
in some of these cases the cause may be genetic.
The prognosis of these patients in terms of seizure outcome was
good, but outcome of language and cognitive functions was
variable. Adequate and early treatment management may avoid
language and cognitive deterioration.
Benign childhood epilepsy with centro-temporal spikes was
recognized in two patients previous to the acquired auditive
agnosia; both these patients also had Panayiotopoulos syndrome.
In our study, the most commonly used treatments were
clobazam, ethosuximide, and sulthiame, alone or in combination.
High-dose steroids were also administered.
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